Aligos Therapeutics Inc. (ALGS) Misses Q4 EPS by 191c

Aligos Therapeutics Inc. (NASDAQ: ALGS) reported Q4 EPS of ($1.91).

For earnings history and earnings-related data on Aligos Therapeutics Inc. (ALGS) click here.

You May Also Be Interested In

• UBS Assumes Interactive Brokers Group (IBKR) at Neutral, 'A Best-in-Class, Yet Fairly Valued Brokerage'
• Goldman Sachs on Kingsoft Cloud (KC): 'AI cloud to drive revenue expansion with attractive investment payback'
• Raymond James Reiterates Strong Buy Rating on Intercontinental Exchange (ICE)